Valbiotis Financial Statements From 2010 to 2024
| ALVAL Stock | EUR 1.39 0.02 1.46% |
Check Valbiotis SAS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Valbiotis SAS's main balance sheet or income statement drivers, such as , as well as many indicators such as . Valbiotis financial statements analysis is a perfect complement when working with Valbiotis SAS Valuation or Volatility modules.
Valbiotis |
Valbiotis SAS Company Shares Outstanding Analysis
Valbiotis SAS's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Valbiotis SAS Shares Outstanding | 12.41 M |
Most of Valbiotis SAS's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valbiotis SAS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Valbiotis SAS has 12.41 M of shares currently outstending. This is 93.13% lower than that of the Biotechnology sector and 88.39% lower than that of the Health Care industry. The shares outstanding for all France stocks is 97.83% higher than that of the company.
Valbiotis SAS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valbiotis SAS's current stock value. Our valuation model uses many indicators to compare Valbiotis SAS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valbiotis SAS competition to find correlations between indicators driving Valbiotis SAS's intrinsic value. More Info.Valbiotis SAS is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Valbiotis SAS's earnings, one of the primary drivers of an investment's value.About Valbiotis SAS Financial Statements
Valbiotis SAS shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Valbiotis SAS investors may analyze each financial statement separately, they are all interrelated. The changes in Valbiotis SAS's assets and liabilities, for example, are also reflected in the revenues and expenses on on Valbiotis SAS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Valbiotis SA develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. Valbiotis SA was founded in 2014 and is based in Prigny, France. VALBIOTIS is traded on Paris Stock Exchange in France.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Valbiotis Stock Analysis
When running Valbiotis SAS's price analysis, check to measure Valbiotis SAS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valbiotis SAS is operating at the current time. Most of Valbiotis SAS's value examination focuses on studying past and present price action to predict the probability of Valbiotis SAS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valbiotis SAS's price. Additionally, you may evaluate how the addition of Valbiotis SAS to your portfolios can decrease your overall portfolio volatility.